Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Incidence, prevalence and risk factors for hepatitis C in Danish prisons

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Strengths and Difficulties Questionnaire and standardized academic tests: Reliability across respondent type and age

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intraoperative flow profiles of arterial and venous bypass grafts to the left coronary territory

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sportsdykning udfordrer både kredsløb og respiration

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: In patients with paroxysmal atrial fibrillation (PAF) or persistent atrial fibrillation (PeAF) symptom burden and fear of hospital readmission are major causes of reduced quality of life. We attempted to develop a prediction model for future atrial fibrillation hospitalization (AFH) risk in PAF and PeAF patients including all previously experienced AFHs in the analysis, as opposed to time to first event.

METHODS: Recurrent event survival analysis was used to model the impact of past AFHs on the risk of future AFHs. A recurrent event was defined as a hospitalization due to a new episode of AF. Death or progression to permanent AF were included as competing risks.

RESULTS: We enrolled 174 patients with PAF or PeAF, mean follow up duration was 1279 days, and 325 AFHs were observed. Median patient age was 63.0 (IQR 52.2-68.0), 29% had PAF, and 71% were male. Highly significant predictors of future AFH risk were PeAF (HR 3.20, CI 2.01-5.11) and number of past AFHs observed (HR for 1 event: 2.97, CI 2.04-4.32, HR for ≥2 events: 7.54, CI 5.47-10.40).

CONCLUSION: In PAF and PeAF patients, AF type and observed AFH frequency are highly significant predictors of future AFH risk. The developed model enables risk prediction in individual patients based on AFH history and baseline characteristics, utilizing all events experienced by the patient. This is the first time recurrent event survival analysis has been used in AF patients.

Original languageEnglish
Article numbere0217983
JournalPLoS One
Volume14
Issue number6
Pages (from-to)e0217983
ISSN1932-6203
DOIs
Publication statusPublished - 1 Jun 2019

ID: 57329502